This statistic depicts the average hospital charges and costs per inpatient HSC transplant patient under Medicaid in 2014, by procedure. According to the data, for a cord blood stem cell transplant under Medicaid, hospital charges were 987,339 U.S. dollars on average and the cost per inpatient stay stood at 296,896 US dollars on average.
Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Cell and gene therapy
Market overview
6
- Basic Statistic Global market size for regenerative medicine 2021-2030
- Premium Statistic Global cell and gene therapy manufacturing market forecast 2023-2033
- Basic Statistic Global cell culture market size 2022-2030
- Premium Statistic ATMP classification share worldwide 2016
- Basic Statistic Regenerative medicine companies by world region 2023
- Basic Statistic Market cap of gene and cell therapy companies 2023
R&D/trials
5
- Premium Statistic ATMP trials classification share by disease and development phase globally 2016
- Premium Statistic ATMP clinical trials share globally by type of sponsor
- Premium Statistic ATMP clinical trials non-commercial sponsors distribution globally 2016
- Premium Statistic Number of biotech therapies in development as of 2017, by developer
- Basic Statistic Percentage of biotech therapies in development as of 2017, by developer
Stem cells
5
- Premium Statistic Global stem cell market size by world region 2011-2016
- Premium Statistic Stem cell technologies and applications market share by world region 2016
- Premium Statistic Global stem cell market size forecast 2022-2030
- Premium Statistic Number of HSC transplants in the US from 2010-2015, by source
- Premium Statistic Total stem cell research funding by the National Institutes for Health 2013-2024
Cord blood
5
- Basic Statistic Aggregate annual demand for cord blood units from 2010-2016
- Premium Statistic Annual social value of U.S. CBB system by scenario 2010-2016
- Premium Statistic Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Basic Statistic Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Premium Statistic Percentage of stored U.S. CBUs by TNC count 2002-2016
CAR/CAR-T
4
Miscellaneous
5
- Basic Statistic Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Premium Statistic Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Premium Statistic Capital raised by regenerative medicine companies worldwide 2016-2022
- Basic Statistic Select market-stage ATMPs price in the U.S. as of 2016
- Premium Statistic View of increasing government funding for stem cell research - U.S. adults 2017
Further related statistics
17
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Most expensive conditions with an expected payer of Medicaid in U.S. hospitals 2017
- Decrease in unpaid hospital bills under Medicaid expansion APril 2015
- Number of HSC transplants in the US from 2010-2015
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Americans' moral stance towards using stem cells obtained from human embryos in 2018
- opioid-related inpatient stay rates by state in U.S. 2014
- Most expensive conditions as share of total U.S. national hospital costs 2017
- Change in rate of opioid-related inpatient stays by US state 2009-2014
- U.S. Medicaid recipient 30-day readmission rates in 2014, by diagnosis
- Annual growth of hospital costs for persons under 65 by diagnosis
- Annual growth of hospital costs for persons 65+ by diagnosis
- Hospital costs in the U.S. by category and payer 2012
- Change in inpatient spending amount per person U.S. 2015-2019
- Tourist satisfaction with medical spending in South Korea 2015
Further Content: You might find this interesting as well
Statistics
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Most expensive conditions with an expected payer of Medicaid in U.S. hospitals 2017
- Decrease in unpaid hospital bills under Medicaid expansion APril 2015
- Number of HSC transplants in the US from 2010-2015
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Americans' moral stance towards using stem cells obtained from human embryos in 2018
- opioid-related inpatient stay rates by state in U.S. 2014
- Most expensive conditions as share of total U.S. national hospital costs 2017
- Change in rate of opioid-related inpatient stays by US state 2009-2014
- U.S. Medicaid recipient 30-day readmission rates in 2014, by diagnosis
- Annual growth of hospital costs for persons under 65 by diagnosis
- Annual growth of hospital costs for persons 65+ by diagnosis
- Hospital costs in the U.S. by category and payer 2012
- Change in inpatient spending amount per person U.S. 2015-2019
- Tourist satisfaction with medical spending in South Korea 2015
RAND Corporation. (September 29, 2017). Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars) [Graph]. In Statista. Retrieved May 04, 2024, from https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/
RAND Corporation. "Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars)." Chart. September 29, 2017. Statista. Accessed May 04, 2024. https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/
RAND Corporation. (2017). Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars). Statista. Statista Inc.. Accessed: May 04, 2024. https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/
RAND Corporation. "Hospital Charges and Costs for An Inpatient Hematopoietic Stem Cell (Hsc) Transplant under Medicaid in 2014, by Procedure (in U.S. Dollars)." Statista, Statista Inc., 29 Sep 2017, https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/
RAND Corporation, Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars) Statista, https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/ (last visited May 04, 2024)
Hospital charges and costs for an inpatient hematopoietic stem cell (HSC) transplant under Medicaid in 2014, by procedure (in U.S. dollars) [Graph], RAND Corporation, September 29, 2017. [Online]. Available: https://www.statista.com/statistics/799959/medicaid-charges-and-costs-for-us-hsc-transplants-by-procedure/